<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Tumors of female reproductive system</journal-id><journal-title-group><journal-title xml:lang="en">Tumors of female reproductive system</journal-title><trans-title-group xml:lang="ru"><trans-title>Опухоли женской репродуктивной системы</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-4098</issn><issn publication-format="electronic">1999-8627</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">414</article-id><article-id pub-id-type="doi">10.17650/1994-4098-2014-0-4-74-82</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>GYNECOLOGY. CLINICAL LECTURE</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ГИНЕКОЛОГИЯ. КЛИНИЧЕСКАЯ ЛЕКЦИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Trophoblastic disease</article-title><trans-title-group xml:lang="ru"><trans-title>Трофобластическая болезнь</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Meshcheryakova</surname><given-names>L. A.</given-names></name><name xml:lang="ru"><surname>Мещерякова</surname><given-names>Л. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>2010am@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N. N. Blokhin Russian Cancer Research Center, Moscow</institution></aff><aff><institution xml:lang="ru">ФГБНУ «РОНЦ им. Н. Н. Блохина», Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2014-11-08" publication-format="electronic"><day>08</day><month>11</month><year>2014</year></pub-date><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>74</fpage><lpage>82</lpage><history><date date-type="received" iso-8601-date="2015-01-06"><day>06</day><month>01</month><year>2015</year></date><date date-type="accepted" iso-8601-date="2015-01-06"><day>06</day><month>01</month><year>2015</year></date></history><permissions><copyright-year>2014</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://ojrs.abvpress.ru/ojrs/article/view/414">https://ojrs.abvpress.ru/ojrs/article/view/414</self-uri><abstract xml:lang="en"><p>Trophoblastic disease encompasses a group of trophoblast abnormalities always associated with pregnancy. The urgency of studying the problemof the diagnosis and treatment of this pathology is clear because of the young age of patients, the high efficiency of treatment for malignant forms of the disease even in distant metastases and the possibility of their complete cure in 98 % of the patients with preserved reproductive function. The keystone of success is the correct and timely diagnosis of the disease and current highly effective treatment in the specialized clinic having all diagnostic facilities and successful experience in treating these patients. Clinicians» knowledge of the problem allows the avoidance of frequent errors both in the diagnosis and choice of treatment policy for patients with malignant trophoblastic tumors that may be fatal for some patients. The paper illustrates theoretical aspects with the results of treatment in patients at the N. N. Blokhin Russian Cancer Research Center that is an expert in the diagnosis and treatment of trophoblastic tumors in Russia. The paper deals with the diagnosis, treatment, and monitoring of trophoblastic disease.</p></abstract><trans-abstract xml:lang="ru"><p>Трофобластическая болезнь включает группу патологических состояний трофобласта, всегда ассоциированных с беременностью. Актуальность изучения проблемы диагностики и лечения данной патологии очевидна в связи с молодым возрастом пациенток, высокой эффективностью лечения злокачественных форм болезни даже при отдаленных метастазах и возможностью полного излечения 98 % больных с сохранением у них репродуктивной функции. Залогом успеха являются: правильная и своевременная диагностика заболевания, проведение современного высокоэффективного лечения в специализированной клинике, обладающей всеми диагностическими возможностями и имеющей успешный опыт лечения таких больных. Знание клиницистами проблемы позволит избежать нередких ошибок как в диагностике, так и в выборе тактики лечения больных злокачественными трофобластическими опухолями, которые могут оказаться для части пациенток фатальными. Статья посвящена вопросам диагностики, лечения и мониторинга трофобластической болезни. Теоретические аспекты иллюстрированы результатами лечения больных в ФГБНУ «РОНЦ им. Н. Н. Блохина», являющемся экспертом в диагностике и лечении трофобластических опухолей в России.</p></trans-abstract><kwd-group xml:lang="en"><kwd>trophoblastic disease</kwd><kwd>malignant trophoblastic tumors</kwd><kwd>hydatidiform mole</kwd><kwd>choriocarcinoma</kwd><kwd>placental bed trophoblastic tumor</kwd><kwd>epitheliod trophoblastic tumor</kwd><kwd>chorionic gonadotropin</kwd><kwd>diagnosis</kwd><kwd>treatment</kwd><kwd>standard chemotherapy</kwd><kwd>histological forms of tropho</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>трофобластическая болезнь</kwd><kwd>злокачественные трофобластические опухоли</kwd><kwd>пузырный занос</kwd><kwd>хориокарцинома</kwd><kwd>трофобластическая опухоль плацентарного ложа</kwd><kwd>эпителиоидная трофобластическая опухоль</kwd><kwd>хорионический гонадотропин</kwd><kwd>диагностика</kwd><kwd>лечение</kwd><kwd>стандартная хими</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Bagshawe K.D. Trophoblastic tumors: diagnostic methods, epidemiology, clinical features and management. Gynecol Оncol 1995;1027–43.</mixed-citation><mixed-citation xml:lang="ru">Bagshawe K.D. Trophoblastic tumors: diagnostic methods, epidemiology, clinical features and management. Gynecol Оncol 1995;1027–43.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Berkowitz R.S., Goldstein D.P. Chorionic tumours. N Engl J Med 1996;335(23):1740–8.</mixed-citation><mixed-citation xml:lang="ru">Berkowitz R.S., Goldstein D.P. Chorionic tumours. N Engl J Med 1996;335(23):1740–8.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Berkowitz R.S., Goldstein D.P. Recent advances in gestational trophoblastic disease. Curr Opin Obstet Gynecol 1998;10(1):61–4.</mixed-citation><mixed-citation xml:lang="ru">Berkowitz R.S., Goldstein D.P. Recent advances in gestational trophoblastic disease. Curr Opin Obstet Gynecol 1998;10(1):61–4.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Ngan H.Y. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Int J Gynecol Cancer 2004;14(2):202–5.</mixed-citation><mixed-citation xml:lang="ru">Ngan H.Y. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Int J Gynecol Cancer 2004;14(2):202–5.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Shimizu T., Yaegashi N. Gestational trophoblastic tumors and recent clinical information. Gan To Kagaku Ryoho 2002;29(8):1363–70.</mixed-citation><mixed-citation xml:lang="ru">Shimizu T., Yaegashi N. Gestational trophoblastic tumors and recent clinical information. Gan To Kagaku Ryoho 2002;29(8):1363–70.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Sugarman S.M., Kavanagh J.J. Gestational trophoblastic tumors. Medical Oncology: a comprehensive review 1993;245–54.</mixed-citation><mixed-citation xml:lang="ru">Sugarman S.M., Kavanagh J.J. Gestational trophoblastic tumors. Medical Oncology: a comprehensive review 1993;245–54.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Wang Y.X., Zhang X., Guan Y.L. et al. Assessment of staging and prognostic scoring system for malignant trophoblastic neoplasia. Zhonghua Fu Chan Ke Za Zhi 2005;40(2): 87–90.</mixed-citation><mixed-citation xml:lang="ru">Wang Y.X., Zhang X., Guan Y.L. et al. Assessment of staging and prognostic scoring system for malignant trophoblastic neoplasia. Zhonghua Fu Chan Ke Za Zhi 2005;40(2): 87–90.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Wolf N.G., Lage J.M. Genetic analysis of gestational trophoblastic disease: a review. Semin Oncol 1995;22(2): 113–8.</mixed-citation><mixed-citation xml:lang="ru">Wolf N.G., Lage J.M. Genetic analysis of gestational trophoblastic disease: a review. Semin Oncol 1995;22(2): 113–8.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Bagshawe K.D. Treatment of high-risk choriocarcinoma. J Reprod Med 1984;29(11):813–20.</mixed-citation><mixed-citation xml:lang="ru">Bagshawe K.D. Treatment of high-risk choriocarcinoma. J Reprod Med 1984;29(11):813–20.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Alifrangis C., Agarwal R., Short D. et al. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction lowdose etoposide-cisplatin and genetic analysis. J Clin Oncol 2013;31(2):280–6.</mixed-citation><mixed-citation xml:lang="ru">Alifrangis C., Agarwal R., Short D. et al. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction lowdose etoposide-cisplatin and genetic analysis. J Clin Oncol 2013;31(2):280–6.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Bolis G., Bonazzi C., Landoni F. et al. EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). Gynecol Oncol 1988;31(3):439–44.</mixed-citation><mixed-citation xml:lang="ru">Bolis G., Bonazzi C., Landoni F. et al. EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). Gynecol Oncol 1988;31(3):439–44.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Bower M., Newlands E.S., Holden L. et al. EMA/CO for high-risk trophoblastic tumor: results from a cohort of 272 patients. J Clin Oncol 1997;15(7):2636–43.</mixed-citation><mixed-citation xml:lang="ru">Bower M., Newlands E.S., Holden L. et al. EMA/CO for high-risk trophoblastic tumor: results from a cohort of 272 patients. J Clin Oncol 1997;15(7):2636–43.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. DeBaz B.P., Lewis T.J. Imaging of gestational trophoblastic disease. Semin Oncol 1995;22(2):130–41.</mixed-citation><mixed-citation xml:lang="ru">DeBaz B.P., Lewis T.J. Imaging of gestational trophoblastic disease. Semin Oncol 1995;22(2):130–41.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Fisher P.M., Hancock B.W. Gestational trophoblastic diseases and their treatment. J Oncol Med 1997;23(1):1–16.</mixed-citation><mixed-citation xml:lang="ru">Fisher P.M., Hancock B.W. Gestational trophoblastic diseases and their treatment. J Oncol Med 1997;23(1):1–16.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Freedman R.S., Tortolero-Luna G., Pandey D.K. et al. Gestational trophoblastic disease. Obstet Gynecol Clin North Am 1996;23(2):545–71.</mixed-citation><mixed-citation xml:lang="ru">Freedman R.S., Tortolero-Luna G., Pandey D.K. et al. Gestational trophoblastic disease. Obstet Gynecol Clin North Am 1996;23(2):545–71.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Lurain J.R. Gestational trophoblastic tumors. Semin Surg Oncol 1990;6(6):347–53.</mixed-citation><mixed-citation xml:lang="ru">Lurain J.R. Gestational trophoblastic tumors. Semin Surg Oncol 1990;6(6):347–53.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Fu J., Fang F., Xie L. et al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev 2012;10:CD007289.</mixed-citation><mixed-citation xml:lang="ru">Fu J., Fang F., Xie L. et al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev 2012;10:CD007289.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Baergen R.N., Rutgers J.L., Young R.H. et al. Placental site trophoblastic tumor: а study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol 2006;100(3):511–20.</mixed-citation><mixed-citation xml:lang="ru">Baergen R.N., Rutgers J.L., Young R.H. et al. Placental site trophoblastic tumor: а study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol 2006;100(3):511–20.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Behnamfar F., Mousavi A., Rezapourian P., Zamani A.E. Placental site trophoblastic tumor, report of a case with unusual presentation. Еur J Nucl Med Mol Imaging 2013;40(4):505–13.</mixed-citation><mixed-citation xml:lang="ru">Behnamfar F., Mousavi A., Rezapourian P., Zamani A.E. Placental site trophoblastic tumor, report of a case with unusual presentation. Еur J Nucl Med Mol Imaging 2013;40(4):505–13.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Deng S., Yang X.Y. Diagnosis and therapeutics of placental site trophoblastic tumor. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2002;24(4):418–21.</mixed-citation><mixed-citation xml:lang="ru">Deng S., Yang X.Y. Diagnosis and therapeutics of placental site trophoblastic tumor. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2002;24(4):418–21.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Hyman D.M., Bakios L., Gualtiere G. et al. Placental site trophoblastic tumor: аnalysis of presentation, treatment, and outcome. Gynecol Oncol 2013;129(1):58–62.</mixed-citation><mixed-citation xml:lang="ru">Hyman D.M., Bakios L., Gualtiere G. et al. Placental site trophoblastic tumor: аnalysis of presentation, treatment, and outcome. Gynecol Oncol 2013;129(1):58–62.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Kim S.J. Placental site trophoblastic tumour. Best Pract Res Clin Obstet Gynaecol 2003;17(6):969–84.</mixed-citation><mixed-citation xml:lang="ru">Kim S.J. Placental site trophoblastic tumour. Best Pract Res Clin Obstet Gynaecol 2003;17(6):969–84.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Moutte A., Doret M., Hajri T. et al. Placental site and epithelioid trophoblastic tumours: diagnostic pitfalls. Gynecol Oncol 2013;128(3):568–72.</mixed-citation><mixed-citation xml:lang="ru">Moutte A., Doret M., Hajri T. et al. Placental site and epithelioid trophoblastic tumours: diagnostic pitfalls. Gynecol Oncol 2013;128(3):568–72.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. Rhoton V.A., Wagner J.M., Rutgers J.L. et al. Placental site trophoblastic tumor: human placental lactogen and pregnancy-associated major basic protein as immunohistologic markers. Hum Pathol 1998;29(3):280–8.</mixed-citation><mixed-citation xml:lang="ru">Rhoton V.A., Wagner J.M., Rutgers J.L. et al. Placental site trophoblastic tumor: human placental lactogen and pregnancy-associated major basic protein as immunohistologic markers. Hum Pathol 1998;29(3):280–8.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25. Shen X., Xiang Y., Guo L. et al. Fertilitypreserving treatment in young patients with placental site trophoblastic tumors. Int J Gynecol Cancer 2012;22(5):869–74.</mixed-citation><mixed-citation xml:lang="ru">Shen X., Xiang Y., Guo L. et al. Fertilitypreserving treatment in young patients with placental site trophoblastic tumors. Int J Gynecol Cancer 2012;22(5):869–74.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26. Allison K.H., Love J.E., Garcia R.L. Epithelioid trophoblastic tumor: review of a rare neoplasm of the chorionic-type intermediate trophoblast. Arch Pathol Lab Med 2006;130(12):1875–7.</mixed-citation><mixed-citation xml:lang="ru">Allison K.H., Love J.E., Garcia R.L. Epithelioid trophoblastic tumor: review of a rare neoplasm of the chorionic-type intermediate trophoblast. Arch Pathol Lab Med 2006;130(12):1875–7.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27. Kuo K.T., Chen M.J., Lin M.C. Epithelioid trophoblastic tumor of the broad ligament: a case report and review of the literature. Am J Surg Pathol 2004;28(3):405–9.</mixed-citation><mixed-citation xml:lang="ru">Kuo K.T., Chen M.J., Lin M.C. Epithelioid trophoblastic tumor of the broad ligament: a case report and review of the literature. Am J Surg Pathol 2004;28(3):405–9.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28. Ohira S., Yamazaki T., Hatano H. еt al. Epithelioid trophoblastic tumor metastatic to the vagina: an immunohistochemical and ultrastructural study. Int J Gynecol Pathol 2000;19(4):381–6.</mixed-citation><mixed-citation xml:lang="ru">Ohira S., Yamazaki T., Hatano H. еt al. Epithelioid trophoblastic tumor metastatic to the vagina: an immunohistochemical and ultrastructural study. Int J Gynecol Pathol 2000;19(4):381–6.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29. Scott E.M., Smith A.L., Desouki M.M., Olawaiye A.B. Epithelioid trophoblastic tumor: a case report and review of the literature. Case Rep Obstet Gynecol 2012;2012:862472.</mixed-citation><mixed-citation xml:lang="ru">Scott E.M., Smith A.L., Desouki M.M., Olawaiye A.B. Epithelioid trophoblastic tumor: a case report and review of the literature. Case Rep Obstet Gynecol 2012;2012:862472.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">30. Sung W.J., Shin H.C., Kim M.K., Kim M.J. Epithelioid trophoblastic tumor: clinicopathologic and immunohistochemical analysis of three cases.Korean J Pathol 2013;47(1):67–73.</mixed-citation><mixed-citation xml:lang="ru">Sung W.J., Shin H.C., Kim M.K., Kim M.J. Epithelioid trophoblastic tumor: clinicopathologic and immunohistochemical analysis of three cases.Korean J Pathol 2013;47(1):67–73.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">31. Vencken P.M., Ewing P.C., Zweemer R.P. Epithelioid trophoblastic tumour: a case report and review of the literature. J Clin Pathol 2006;59(12):1307–8.</mixed-citation><mixed-citation xml:lang="ru">Vencken P.M., Ewing P.C., Zweemer R.P. Epithelioid trophoblastic tumour: a case report and review of the literature. J Clin Pathol 2006;59(12):1307–8.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">32. Tsukamoto N., Iwasaka T., Kashimura Y. et al. Gestational trophoblastic disease in women aged 50 or more. Gynecol Oncol 1985;20(1):53–61.</mixed-citation><mixed-citation xml:lang="ru">Tsukamoto N., Iwasaka T., Kashimura Y. et al. Gestational trophoblastic disease in women aged 50 or more. Gynecol Oncol 1985;20(1):53–61.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">33. Hasanzadeh M., Sharifi N., Esmaieli H. et al. Immunohistochemical expression of the proliferative marker Ki67 in hydatidiformmoles and its diagnostic value in the progression to gestational trophoblastic neoplasia. J Obstet Gynaecol Res 2013;39(2):572–7.</mixed-citation><mixed-citation xml:lang="ru">Hasanzadeh M., Sharifi N., Esmaieli H. et al. Immunohistochemical expression of the proliferative marker Ki67 in hydatidiformmoles and its diagnostic value in the progression to gestational trophoblastic neoplasia. J Obstet Gynaecol Res 2013;39(2):572–7.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">34. Betel C., Atri M., Arenson A.M., Khalifa M. et al. Sonographic diagnosis of gestational trophoblastic disease and comparison with retained products of conception. Ultrasound Med 2006;25(8):985–93.</mixed-citation><mixed-citation xml:lang="ru">Betel C., Atri M., Arenson A.M., Khalifa M. et al. Sonographic diagnosis of gestational trophoblastic disease and comparison with retained products of conception. Ultrasound Med 2006;25(8):985–93.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">35. Bidzinski M., Lemieszczuk B., Drabik M. The assessement of value of transvaginal ultrasound for monitoring of gestational trophoblastic diseases treatment. Eur J Gynaecol Oncol 1997;18(6):541–3.</mixed-citation><mixed-citation xml:lang="ru">Bidzinski M., Lemieszczuk B., Drabik M. The assessement of value of transvaginal ultrasound for monitoring of gestational trophoblastic diseases treatment. Eur J Gynaecol Oncol 1997;18(6):541–3.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">36. Kohorn E.I., McCarthy S.M., Taylor K.J. Nonmetastatic gestational trophoblastic neoplasia: role of ultrasonography and magnetic resonance imaging. J Reprod Med Obstet Gynecol 1998;43(1):14–20.</mixed-citation><mixed-citation xml:lang="ru">Kohorn E.I., McCarthy S.M., Taylor K.J. Nonmetastatic gestational trophoblastic neoplasia: role of ultrasonography and magnetic resonance imaging. J Reprod Med Obstet Gynecol 1998;43(1):14–20.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">37. Nikolic B., Lukic R. Choriocarcinoma – post disease ultrasonographic findings. Int J Gynecol Cancer 2004;14(4):677–9.</mixed-citation><mixed-citation xml:lang="ru">Nikolic B., Lukic R. Choriocarcinoma – post disease ultrasonographic findings. Int J Gynecol Cancer 2004;14(4):677–9.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">38. Chang T.C., Yen T.C., Li Y.T. et al. The role of 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study. Eur J Nucl Med Mol Imaging 2006;33(2):156–63.</mixed-citation><mixed-citation xml:lang="ru">Chang T.C., Yen T.C., Li Y.T. et al. The role of 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study. Eur J Nucl Med Mol Imaging 2006;33(2):156–63.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">39. Dhillon T., Palmieri C., Sebire N.J. et al. Value of whole body 18FDG-PET to identify the active site of gestational trophoblastic neoplasia. J Reprod Med 2006;51(11):879–87.</mixed-citation><mixed-citation xml:lang="ru">Dhillon T., Palmieri C., Sebire N.J. et al. Value of whole body 18FDG-PET to identify the active site of gestational trophoblastic neoplasia. J Reprod Med 2006;51(11):879–87.</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">40. Lai C.H., Yen T.C., Chang T.C. Positron emission tomography imaging for gynecologic malignancy. Curr Opin Obstet Gynecol 2007;19(1):37–41.</mixed-citation><mixed-citation xml:lang="ru">Lai C.H., Yen T.C., Chang T.C. Positron emission tomography imaging for gynecologic malignancy. Curr Opin Obstet Gynecol 2007;19(1):37–41.</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">41. Mapelli P., Mangili G., Picchio M. et al. Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia. Eur J Nucl Med Mol Imaging 2013;40(4): 505–13.</mixed-citation><mixed-citation xml:lang="ru">Mapelli P., Mangili G., Picchio M. et al. Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia. Eur J Nucl Med Mol Imaging 2013;40(4): 505–13.</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">42. Sironi S., Picchio M., Mangili G. et al. [18F]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients. Gynecol Oncol 2003;91(1):226–30.</mixed-citation><mixed-citation xml:lang="ru">Sironi S., Picchio M., Mangili G. et al. [18F]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients. Gynecol Oncol 2003;91(1):226–30.</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">43. McNeish I.A., Stricland S., Holden L. et al. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment withlow-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 2002;20(7):1838–44.</mixed-citation><mixed-citation xml:lang="ru">McNeish I.A., Stricland S., Holden L. et al. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment withlow-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 2002;20(7):1838–44.</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">44. Ghaemmaghami F., Modares M., Arab M. et al. EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II–IV). Int J Gynecol Cancer 2004;14(2):360–5.</mixed-citation><mixed-citation xml:lang="ru">Ghaemmaghami F., Modares M., Arab M. et al. EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II–IV). Int J Gynecol Cancer 2004;14(2):360–5.</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">45. Lurain J.R., Nejad B., John I. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. Gynecol Oncol 2005;97(2):618–23.</mixed-citation><mixed-citation xml:lang="ru">Lurain J.R., Nejad B., John I. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. Gynecol Oncol 2005;97(2):618–23.</mixed-citation></citation-alternatives></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">46. Lybol C., Thomas C.M., Blanken E.A. et al. Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia. Eur J Cancer 2013;49(4):860–7.</mixed-citation><mixed-citation xml:lang="ru">Lybol C., Thomas C.M., Blanken E.A. et al. Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia. Eur J Cancer 2013;49(4):860–7.</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><citation-alternatives><mixed-citation xml:lang="en">47. Lybol C., Westerdijk K., Sweep F.C. et al. Human chorionic gonadotropin (hCG) regression normograms for patients with highrisk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy. Ann Oncol 2012;23(11):2903–6.</mixed-citation><mixed-citation xml:lang="ru">Lybol C., Westerdijk K., Sweep F.C. et al. Human chorionic gonadotropin (hCG) regression normograms for patients with highrisk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy. Ann Oncol 2012;23(11):2903–6.</mixed-citation></citation-alternatives></ref><ref id="B48"><label>48.</label><citation-alternatives><mixed-citation xml:lang="en">48. Alazzam M., Tidy J., Osborne R. et al. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev 2012;12:CD008891.</mixed-citation><mixed-citation xml:lang="ru">Alazzam M., Tidy J., Osborne R. et al. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev 2012;12:CD008891.</mixed-citation></citation-alternatives></ref><ref id="B49"><label>49.</label><citation-alternatives><mixed-citation xml:lang="en">49. Meshcheryakova L.A., Kozachenko V.P., Meshcheryakov A.A. Chemotherapy in resistant gestational trophoblastic tumor (GTT). Int J Gynecol Cancer 2003;13(1):102.</mixed-citation><mixed-citation xml:lang="ru">Meshcheryakova L.A., Kozachenko V.P., Meshcheryakov A.A. Chemotherapy in resistant gestational trophoblastic tumor (GTT). Int J Gynecol Cancer 2003;13(1):102.</mixed-citation></citation-alternatives></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">50. Newlands E.S., Bower M., Holden L. et al. Management of resistant gestational trophoblastic tumors. J Reprod Med Obstet Gynecol 1998;43(2):111–8.</mixed-citation><mixed-citation xml:lang="ru">Newlands E.S., Bower M., Holden L. et al. Management of resistant gestational trophoblastic tumors. J Reprod Med Obstet Gynecol 1998;43(2):111–8.</mixed-citation></citation-alternatives></ref><ref id="B51"><label>51.</label><citation-alternatives><mixed-citation xml:lang="en">51. Alifrangis C., Wilkinson M.J., Stefanou D.C. et al. Role of thoracotomy and metastatectomy in gestational trophoblastic neoplasia: a single center experience. J Reprod Med 2012;57(7–8):350–8.</mixed-citation><mixed-citation xml:lang="ru">Alifrangis C., Wilkinson M.J., Stefanou D.C. et al. Role of thoracotomy and metastatectomy in gestational trophoblastic neoplasia: a single center experience. J Reprod Med 2012;57(7–8):350–8.</mixed-citation></citation-alternatives></ref><ref id="B52"><label>52.</label><citation-alternatives><mixed-citation xml:lang="en">52. Lurain J.R., Singh D.K., Schink J.C., John I. Role of surgery in the management of high-risk gestational trophoblastic neoplasia. J Reprod Med 2006;51(10):773–6.</mixed-citation><mixed-citation xml:lang="ru">Lurain J.R., Singh D.K., Schink J.C., John I. Role of surgery in the management of high-risk gestational trophoblastic neoplasia. J Reprod Med 2006;51(10):773–6.</mixed-citation></citation-alternatives></ref><ref id="B53"><label>53.</label><citation-alternatives><mixed-citation xml:lang="en">53. Pires L.V., Uberti E.M., Fajardo Mdo C. et al. Role of hysterectomy in the management of patients with gestational trophoblastic neoplasia: importance of receiving treatment in reference centers. J Reprod Med 2012; 57(7–8):359–68.</mixed-citation><mixed-citation xml:lang="ru">Pires L.V., Uberti E.M., Fajardo Mdo C. et al. Role of hysterectomy in the management of patients with gestational trophoblastic neoplasia: importance of receiving treatment in reference centers. J Reprod Med 2012; 57(7–8):359–68.</mixed-citation></citation-alternatives></ref><ref id="B54"><label>54.</label><citation-alternatives><mixed-citation xml:lang="en">54. Sablinska B., Kietlinska Z., Zielinski J. Chemotherapy combined with surgery in the treatment of gestational trophoblastic disease (GTD). Eur J Gynaecol Oncol 1993; 14 Suppl:146–51.</mixed-citation><mixed-citation xml:lang="ru">Sablinska B., Kietlinska Z., Zielinski J. Chemotherapy combined with surgery in the treatment of gestational trophoblastic disease (GTD). Eur J Gynaecol Oncol 1993; 14 Suppl:146–51.</mixed-citation></citation-alternatives></ref><ref id="B55"><label>55.</label><citation-alternatives><mixed-citation xml:lang="en">55. Sergent F., Verspyck E., Lemoine J.P., Marpeau L. Place of surgery in the management of gestational trophoblastic tumors. Gynecol Obstet Fertil 2006; 34(7–8):670.</mixed-citation><mixed-citation xml:lang="ru">Sergent F., Verspyck E., Lemoine J.P., Marpeau L. Place of surgery in the management of gestational trophoblastic tumors. Gynecol Obstet Fertil 2006; 34(7–8):670.</mixed-citation></citation-alternatives></ref><ref id="B56"><label>56.</label><citation-alternatives><mixed-citation xml:lang="en">56. Zhang Y., Xiang Y., Ren T. et al. Study on the indication of surgical resection of pulmonary metastasis of malignant trophoblastic tumor. Zhonghua Fu Chan Ke Za Zhi 2005;40(2):83–6.</mixed-citation><mixed-citation xml:lang="ru">Zhang Y., Xiang Y., Ren T. et al. Study on the indication of surgical resection of pulmonary metastasis of malignant trophoblastic tumor. Zhonghua Fu Chan Ke Za Zhi 2005;40(2):83–6.</mixed-citation></citation-alternatives></ref><ref id="B57"><label>57.</label><citation-alternatives><mixed-citation xml:lang="en">57. Cagayan M.S., Lu-Lasala L.R. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: a 12-year review at the Philippine General Hospital. J Reprod Med 2006;51(10):785–92.</mixed-citation><mixed-citation xml:lang="ru">Cagayan M.S., Lu-Lasala L.R. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: a 12-year review at the Philippine General Hospital. J Reprod Med 2006;51(10):785–92.</mixed-citation></citation-alternatives></ref><ref id="B58"><label>58.</label><citation-alternatives><mixed-citation xml:lang="en">58. Evans A.C. Jr., Soper J.T., Clarke-Pearson D.L. et al. Gestational trophoblastic disease metastatic to the entral nervous system. Gynecol Oncol 1995;59(2):226–30.</mixed-citation><mixed-citation xml:lang="ru">Evans A.C. Jr., Soper J.T., Clarke-Pearson D.L. et al. Gestational trophoblastic disease metastatic to the entral nervous system. Gynecol Oncol 1995;59(2):226–30.</mixed-citation></citation-alternatives></ref><ref id="B59"><label>59.</label><citation-alternatives><mixed-citation xml:lang="en">59. Neubauer N.L., Latif N., Kalakota K. et al. Brain metastasis in gestational trophoblastic neoplasia: an update. J Reprod Med 2012;57(7–8):288–92.</mixed-citation><mixed-citation xml:lang="ru">Neubauer N.L., Latif N., Kalakota K. et al. Brain metastasis in gestational trophoblastic neoplasia: an update. J Reprod Med 2012;57(7–8):288–92.</mixed-citation></citation-alternatives></ref><ref id="B60"><label>60.</label><citation-alternatives><mixed-citation xml:lang="en">60. Schechter N.R., Mychalczak B., Jones W. et al. Prognosis of patients treated with wholebrain radiation therapy for metastatic gestational trophoblastic disease. Gynecol Oncol 1998;68(2):183–92.</mixed-citation><mixed-citation xml:lang="ru">Schechter N.R., Mychalczak B., Jones W. et al. Prognosis of patients treated with wholebrain radiation therapy for metastatic gestational trophoblastic disease. Gynecol Oncol 1998;68(2):183–92.</mixed-citation></citation-alternatives></ref><ref id="B61"><label>61.</label><citation-alternatives><mixed-citation xml:lang="en">61. Semple P.L., Denny L., Coughlan M. et al. The role neurosurgery in the treatment of cerebral metastases from choriocarcinoma: a report of two cases. Int J Gynecol Cancer 2004;14(1):157–61.</mixed-citation><mixed-citation xml:lang="ru">Semple P.L., Denny L., Coughlan M. et al. The role neurosurgery in the treatment of cerebral metastases from choriocarcinoma: a report of two cases. Int J Gynecol Cancer 2004;14(1):157–61.</mixed-citation></citation-alternatives></ref><ref id="B62"><label>62.</label><citation-alternatives><mixed-citation xml:lang="en">62. Soper J.T., Spillman M., Sampson J.H. et al. High-risk gestational trophoblastic neoplasia with brain metastases: Individualized multidisciplinary therapy in the management of four patients. Gynecol Oncol 2007;104(3):691–4.</mixed-citation><mixed-citation xml:lang="ru">Soper J.T., Spillman M., Sampson J.H. et al. High-risk gestational trophoblastic neoplasia with brain metastases: Individualized multidisciplinary therapy in the management of four patients. Gynecol Oncol 2007;104(3):691–4.</mixed-citation></citation-alternatives></ref><ref id="B63"><label>63.</label><citation-alternatives><mixed-citation xml:lang="en">63. Yang J.J., Xiang Y., Yang X.Y. et al. Evaluation of emergency craniotomy for the treatment of patients with intracranial metastases of choriocarcinoma. Zhonghua Fu Chan Ke Za Zhi 2005;40(5):335–8.</mixed-citation><mixed-citation xml:lang="ru">Yang J.J., Xiang Y., Yang X.Y. et al. Evaluation of emergency craniotomy for the treatment of patients with intracranial metastases of choriocarcinoma. Zhonghua Fu Chan Ke Za Zhi 2005;40(5):335–8.</mixed-citation></citation-alternatives></ref><ref id="B64"><label>64.</label><citation-alternatives><mixed-citation xml:lang="en">64. Bates M., Everard J., Wall L. et al. Is there a relationship between treatment for infertility and gestational trophoblastic disease? Hum Reprod 2004;19(2):365–7.</mixed-citation><mixed-citation xml:lang="ru">Bates M., Everard J., Wall L. et al. Is there a relationship between treatment for infertility and gestational trophoblastic disease? Hum Reprod 2004;19(2):365–7.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
